What to do when a claimant refuses to change medications | IMM

What to do when a claimant refuses to change medications

Managing resistance to deprescribing and medication optimization on insurance claims

Published: 3 April 2026 | Updated: 3 April 2026

The resistance problem

You've arranged a medication review. The pharmacist has identified unnecessary medications. Your medical advisor has recommended deprescribing. The treating doctor has agreed. Everything points to the same conclusion: this claimant should reduce or stop medications that aren't helping and are creating side effects. And then the claimant says no.

Claimant resistance to medication change is one of your most frustrating claim management challenges. You can't force someone to take medications off their own account. You can recommend, pressure, even make case decisions based on non-compliance, but ultimately the claimant has agency over their own body. How do you navigate that without losing control of the claim?

The answer lies in understanding why they're refusing, distinguishing between legitimate concerns and entrenched thinking, and knowing which battles you need to win and which you can concede. Some refusals are predictable; others reflect genuine clinical concerns you haven't yet addressed.

Key insight: Claimant refusal to change medications is often a signal that something in your clinical argument isn't working. Before you push harder, listen harder.

Step 1: Understand the nature of the refusal

Claimants refuse medication changes for different reasons, and your response should differ depending on which reason applies. Start by asking open questions: "I notice you don't want to reduce the medication. Can you tell me what your concerns are?"

Type 1: Fear of withdrawal or worsening pain

The claimant believes that stopping the medication will cause withdrawal effects or their pain will immediately escalate. This is very common with long-term opioid or benzodiazepine use. Even when you explain that reduction will be gradual, the claimant remains convinced they'll suffer.

This fear is often well-founded from previous experience. If they've tried stopping a medication in the past and experienced severe withdrawal or pain escalation, they're responding rationally based on that history. Your response needs to address their specific concern: "What happened last time you tried to reduce this medication?" Listen to the details. If the previous attempt wasn't well-managed, acknowledge that and explain what would be different this time.

Type 2: Emotional attachment to the medication

The claimant sees the medication as what's keeping them functional. Even if objective evidence shows the medication isn't effective, they're convinced that it is. This is particularly common with long-term therapies. They've been on the medication for years; it's become part of their identity as a person with a medical condition.

Challenging this attachment directly rarely works. Instead, reframe the goal: "We're not trying to make you suffer. We're trying to find the most effective combination that lets you do the things you want to do. Some of the medications you're on might actually be getting in the way of that."

Type 3: Distrust of the healthcare system or the insurer

The claimant doesn't trust your motivation. They think you're trying to cut costs at the expense of their care. They may have experienced prior negative interactions with claims management, or they may be deeply suspicious of insurance companies. This refusal is about trust, not medication.

This requires a different approach entirely. You need to demonstrate that the recommendation is clinically sound, comes from their treating doctor, and isn't financially motivated. Involving an independent third-party opinion (like a medication review pharmacist) can help. You might say: "I've asked an independent pharmacy specialist to review your medications. They're not employed by the insurer, and they focus purely on whether your medications are working. Let's see what they recommend."

Type 4: Genuine clinical concerns

Sometimes the claimant is right. They have legitimate concerns about medication changes that haven't been adequately addressed. Maybe the proposed deprescribing schedule is too fast. Maybe there are drug interactions the reviewer didn't catch. Maybe they have comorbidities that make the proposed change risky. Listen carefully and seek clinical clarification.

If a claimant is refusing medication change and you can't articulate their specific reason, you don't yet understand the situation well enough to proceed.

Step 2: Verify the clinical recommendation is sound

Before managing claimant resistance, make sure the recommendation to change medications is actually clinically justified. Review the evidence:

  • Is the medication demonstrably ineffective (objective evidence, not just subjective symptoms)?
  • Are there side effects that are worsening function or safety?
  • Would removal of the medication improve overall medication burden without harming outcomes?
  • Has the recommending pharmacist or doctor considered the claimant's comorbidities and prior medication reactions?

If the recommendation is based on "this claimant is on too many medications" without clear evidence that the specific medication is harmful or ineffective, that's not a strong enough clinical basis. The claimant's instinct to resist might be correct.

If you're not convinced the clinical recommendation is sound, don't back it. Say to the claimant: "I want to look into this more before we make changes. Let me get another opinion." This actually strengthens your position. It shows you're being thoughtful about their care, not just pushing an agenda.

Step 3: Develop a collaborative response

Once you understand the refusal and have verified the clinical recommendation is sound, work collaboratively with the claimant, their treating doctor, and the pharmacist (if one is involved) to design a change the claimant can accept.

Refusal type Collaborative approach Likely outcome
Fear of withdrawal Work with treating doctor to design a slower tapering schedule; schedule regular reviews to adjust if withdrawal occurs; offer pharmacist support during taper Claimant more likely to attempt change if they feel it's controlled and reversible
Emotional attachment Involve pharmacist in conversation about medication effectiveness; discuss how reducing problematic medications might improve quality of life; establish measurable goals for the change (e.g. better sleep, improved function) Claimant may accept change if positioned as improvement, not loss
Distrust of system Bring in independent medical opinion; have treating doctor lead the recommendation; involve pharmacist as neutral expert; document that change is clinically driven, not cost-driven Claimant more likely to trust if recommendation comes from multiple independent sources
Genuine clinical concerns Address the specific concern with the treating doctor; seek specialist input if needed; modify the recommendation to address the concern; explain why the change is still warranted Claimant more likely to engage if their specific concern is heard and addressed

The key shift is from "you need to change your medications" to "let's work together to figure out what medication changes would be safe and acceptable for you." This small linguistic shift often changes the entire dynamic.

Action: Collaborative conversation framework

  1. Acknowledge the claimant's concern: "I hear that you're worried about stopping this medication. That's a valid concern."
  2. Explain why change is recommended: "Here's what we're seeing in your regimen and why we think a change might help."
  3. Address their specific fear: "Let's talk about how to make this change in a way that feels safe for you."
  4. Involve the treating doctor: "Your doctor supports this change. Let's talk with them about the approach."
  5. Establish a plan together: "How quickly do you feel comfortable making this change? What would we need to monitor to make sure it's working?"
  6. Set a review point: "Let's check in after four weeks to see how you're going. If it's not working, we can adjust."

Step 4: Know when to step back and when to push

Not every medication change is worth the battle. You need to distinguish between essential changes and optimal changes. Essential changes are those where the medication poses genuine safety risk or is actively harming the claimant. Optimal changes are those where the regimen could be more efficient but isn't creating harm.

Change type Definition How to handle refusal
Essential change Medication poses overdose risk, creates dangerous interactions, or is causing serious harm; safety issue is objective and clear Push harder; this is non-negotiable. Involve treating doctor, medical advisor, and pharmacist. Document that you've recommended change and claimant has refused. Consider case management actions.
Strongly recommended change Medication is ineffective, creating problematic side effects, or contributing to poor outcomes; clinical case is clear but not immediately dangerous Explore reasons for refusal collaboratively. Try to design a change the claimant will accept. If refusal persists after genuine attempt at collaboration, document and move to monitoring.
Optimal change Medication could be removed or reduced as part of regimen optimization; not creating harm but could improve efficiency; more cost-focused than clinical benefit If claimant refuses and isn't harmed, consider backing off. Revisit if circumstances change. This is lower priority than other changes.

This framework prevents you from wasting energy on battles that don't matter while ensuring you don't back down on changes that do. A claimant refusing to optimise from five medications to four can usually be tolerated. A claimant refusing to deprescribe a medication that's causing overdose risk cannot.

Step 5: Document the refusal and your response

If the claimant refuses a clinically recommended medication change, document it clearly. Record what was recommended, why, who recommended it, what the claimant's concerns were, and what response you offered. This documentation protects you if the claim later deteriorates or there are adverse events.

Your documentation should convey that you acted professionally and in the claimant's interests, even though they declined the recommendation. Avoid language that sounds punitive or judgmental. Instead, record the facts: "Pharmacist recommended deprescribing tramadol due to ineffectiveness and side effects. Claimant expressed concern about withdrawal. Offered slower tapering schedule. Claimant declined to proceed at this time. Treating doctor aware of refusal. Recommended revisiting in six weeks."

Documentation standard: Your notes should be clear enough that a reasonable third party (regulator, court, claims auditor) would understand that you had identified a medication issue, had offered a reasonable solution, and had documented the claimant's refusal and your response.

Step 6: Monitor and revisit

A claimant's refusal today doesn't have to be final. Many claimants who refuse medication changes initially accept them later, once they've had time to think, discuss with their doctor, or experience the continuation of side effects or poor outcomes.

Schedule a follow-up conversation in 3-6 months. Check in: "We talked about reducing the tramadol a few months ago. Has anything changed? Are you open to reconsidering?" Often, the answer is yes. The initial refusal was about fear or unfamiliarity; once some time has passed, the calculus changes.

Also monitor the outcomes. If the claimant's condition deteriorates while on the unchanged regimen, or if new problems emerge, you have additional evidence to support revisiting the medication change discussion.

Scenarios and responses

Scenario A: Claimant fears withdrawal from benzodiazepine

The claimant has been on a long-acting benzodiazepine for years. You've recommended deprescribing. They say: "The last time I tried to stop, I had terrible anxiety and couldn't sleep."

Response: Acknowledge that experience was real and difficult. Explain that the previous attempt was probably too fast. Involve the treating doctor in designing a much slower taper: perhaps 10% reduction every 2-4 weeks over months rather than weeks. Offer pharmacist support during the process. Clearly separate the fear (legitimate) from the solution (a properly managed taper is different from the claimant's previous experience).

Scenario B: Claimant convinced medication is essential despite poor evidence

The claimant has been on a medication for so long they're certain it's working, even though recent assessments suggest minimal benefit. They say: "I'd be in agony without this medication."

Response: Explore what "without this medication" looks like in their mind. Has the claimant actually tried stopping, or is this fear based on something else? Involve the pharmacist in discussing their actual medication response: "Let's look at what's happening when you take the medication versus what you expect would happen if you didn't." Sometimes you'll discover the claimant hasn't actually taken the medication as prescribed, or has taken a lower dose without telling anyone. Other times you'll discover their fear is reasonable given past experience. Design a trial: "Let's reduce just slightly and carefully monitor what happens. We can always go back up."

Scenario C: Claimant doesn't trust the insurer's motive

The claimant is suspicious: "You just want to cut costs, not help me."

Response: This is the hardest refusal to overcome because it's not about medication; it's about trust. Bring in independent expertise: "I've asked an independent pharmacist to review your medications without any involvement from the insurer. They're going to give us their professional opinion on what would help you most." When the independent pharmacist recommends the same change, the claimant's trust in the recommendation increases significantly. Also involve the treating doctor: ensure they're actively supporting the change, not just passively accepting your suggestion.

Summary: Your action plan

When a claimant refuses medication change, your first step is always to understand why. Listen to their specific concern. Then verify that the clinical recommendation is actually justified. If it is, work collaboratively with the claimant, treating doctor, and if appropriate a pharmacist to design a change they can accept. Distinguish between essential changes (you must push) and optimal changes (you can tolerate refusal). Document everything. Revisit the conversation periodically because refusals can change.

Claimant resistance often signals that something in your clinical argument isn't resonating. Rather than pushing harder, it's usually more effective to step back, listen, and redesign the approach. That's how you move from resistance to collaboration.

Medication refusal requires careful clinical navigation

IMM's pharmacists excel at understanding claimant concerns and designing medication changes they can accept. We work collaboratively with treating doctors and claimants to build consensus around medication optimizations that improve outcomes and reduce resistance.

Request a Medication Review

This article was prepared by the clinical pharmacy team at IMM (Independent Medication Management), Australia's specialist provider of medication reviews for the insurance industry. IMM works with insurers across workers compensation, CTP, life insurance, and NDIS schemes to deliver pharmacist-led medication management that improves claimant outcomes and reduces medication-related risk. Learn more about IMM's services.

Evidence-Based Medication Oversight for Better Claim Outcomes

Expert pharmacy reviews and medication management services that help claims teams make confident, informed decisions about medication-related claims.

Got Questions? Speak to an Independent Pharmacist

Unbiased advice on your claimant's medications and recovery plan.